Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Paul Awolade to Hypoglycemic Agents

This is a "connection" page, showing publications Paul Awolade has written about Hypoglycemic Agents.

 
Connection Strength
 
 
 
0.325
 
  1. Gummidi L, Kerru N, Ebenezer O, Awolade P, Sanni O, Islam MS, Singh P. Multicomponent reaction for the synthesis of new 1,3,4-thiadiazole-thiazolidine-4-one molecular hybrids as promising antidiabetic agents through a-glucosidase and a-amylase inhibition. Bioorg Chem. 2021 10; 115:105210.
    View in: PubMed
    Score: 0.117
  2. Seboletswe P, Awolade P, Singh P. Recent Developments on the Synthesis and Biological Activities of Fused Pyrimidinone Derivatives. ChemMedChem. 2021 07 06; 16(13):2050-2067.
    View in: PubMed
    Score: 0.115
  3. Kerru N, Singh-Pillay A, Awolade P, Singh P. Current anti-diabetic agents and their molecular targets: A review. Eur J Med Chem. 2018 May 25; 152:436-488.
    View in: PubMed
    Score: 0.093
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)